Business
Avalon GloboCare describes itself as a technology-innovation company focused on consumer health and technology markets, while also seeking AI acquisitions.
Avalon GloboCare had no FY2025 revenue in the local rows, and its net loss widened to $18.3M.
The read at a glance✓ Audited against SEC data
- Business mix — Consumer health and AI-content transitionWatch
- Revenue — Revenue fell to zeroWatch
- Profitability — Net loss widened to $18.3MWatch
- SBC — SBC rose to $1.8MWatch
- Balance sheet — Equity improved to $9.2MOK
- Insiders — 0 buys / 0 sellsNote
- Accounting — Altman-Z distress; other scores unavailableWatch
Where the revenue comes from
Fiscal 2024, as Avalon GloboCare Corp. reports it. History and quarterly detail are in the app.
- Real Property Operations$1.3M
Leadership changes
From Avalon GloboCare Corp.'s own filings, the day they're filed.
- Luisa Ingargiola · Chief Strategy Officer · appointmenteff. 2026-06-03
- Lourdes Felix · director · appointmenteff. 2026-02-24
Latest filings
- 8-K · Company announcement2026-08-31
- 8-K · Company announcement2026-08-31
- 8-K · Company announcement2026-08-24
- 8-K · Company announcement2026-08-18
- 10-Q · Quarterly report2026-08-14
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- Main tension🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Avalon GloboCare Corp., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.